Share Price:

APNASPENAspen Pharmacare Hldgs2324952 (0.22%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Aspen announces R500 million investment at 4th SAIC

President Cyril Ramaphosa thanks Stavros Nicolaou for Aspen's R500 million pledge

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha. The announcement comes in the wake of more than R8 billion which Aspen has already invested in this world class… Continue reading Aspen announces R500 million investment at 4th SAIC

Aspen helps evacuate SA students stranded in the Ukraine

Aspen partnered with the the South African Department of International Relations and Cooperation to repatriate students from the Ukraine

Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International Relations and Cooperation (“DIRCO”) to assist in the emergency evacuation of South African students who have been studying at various Universities… Continue reading Aspen helps evacuate SA students stranded in the Ukraine

Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa

Stephen Saad, Aspen Group Chief Executive

“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.

Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Stephen Saad, Aspen Group Chief Executive accepting the 2022 Economic Diplomacy (Global) Ubuntu Award Photo Credits: DIRCO

Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and Department of International Relations and Cooperations’ (“DIRCO”) Ubuntu Award in the Economic Diplomacy (Global) category at its prestigious 6th annual awards ceremony hosted in Cape Town for this purpose. This… Continue reading Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to confirm that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA”), has confirmed a non-binding term sheet with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen… Continue reading Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa

Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

Aspen Chairman Kuseni Dlamini (far left) welcoming Kenyan President His Excellency President Uhuru Kenyatta (centre) together with Aspen’s Stavros Nicolaou, Senior Executive Strategic Trade (far right)

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha. President Kenyatta’s visit to Aspen forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa’s dependence on… Continue reading Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line

Stephen Saad, Aspen Group Chief Executive (left) and Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel at the unveiling of Aspen's general anaesthetics manufacturing line in Gqeberha, South Africa

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted the Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel who officially opened Aspen’s world class general anaesthetics production line at its Gqeberha-based flagship manufacturing site. This manufacturing capability will convert Aspen’s Gqeberha facility into one of the largest manufacturing… Continue reading Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line

Aspen increases revenue from continuing operations by 12% to R37,8 billion

Stephen Saad, Aspen Group Chief Executive

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report the following salient financial results for the year ended 30 June 2021: *The prior year comparatives for continuing operations have been restated to include the discontinued European business within discontinued operations in compliance with IFRS… Continue reading Aspen increases revenue from continuing operations by 12% to R37,8 billion

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.